Get startedLog in
    Picture of NOMAD Power Solutions logo

    NMAD — NOMAD Power Solutions News Story

    0.000.00%
    us flag iconLast trade - 00:00
    IndustrialsSpeculativeMicro CapSucker Stock
    All News

    Brief: LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI

    Picture of NOMAD Power Solutions logoNOMAD Power Solutions
    26/02/2024 13:34
    Feb 26 (Reuters) - Lixte Biotechnology Holdings Inc
 LIXT.O :
    * LIXTE BIOTECHNOLOGY ENTERS INTO EXCLUSIVE IMMUNE ONCOLOGY
PATENT
LICENSE AGREEMENT WITH NINDS AND NCI

Source text for Eikon:  ID:nGNX6jWkwn 
Further company coverage:  LIXT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on NOMAD Power Solutions

    See all news